In Guidelines

About half of our reviews are cited in guidelines and have made significant impact upon policy making. These range from NICE, in the UK, to WHO, globally. 

Some examples:

Scottish Intercollegiate Guidelines Network (SIGN). Risk estimation and the prevention of cardiovascular disease. Edinburgh: SIGN; 2017 June. (SIGN publication no. 149).  

National Collaborating Centre for Primary Care; National Institute for Health and Care Excellence (commissioner). Identification and management of familial hypercholesterolaemia (FH). London: Royal College of General Practitioners. [Updated November 2017. (NICE CG71).

National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Chest pain [last revised January 2017]. London: National Institute for Health and Care Excellence; 2017 January. 

Baumgartner H, Falk V, Bax JJ,  De Bonis M, Hamm C, Holm PJ, et al.; European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS). 2017 ESC/EACTS Guidelines for the management of valvular heart disease. European Heart Journal.  2017 September;38(36):2739–2791. doi:10.1093/eurheartj/ehx391.  

Scottish Intercollegiate Guidelines Network (SIGN). Management of chronic heart failure. Edinburgh: SIGN; 2016 (SIGN publication no. 147). [Issued March 2016]. 

National Clinical Guidelines Centre, National Institute for Health and Care Excellence (commissioner). Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. London: National Institute for Health and Care Excellence; 2014 (NICE CG181). [Issued July 2014, updated September 2016]. 

Anderson TJ, Grégoire J, Pearson GJ, Barry AR, Couture P, Dawes M, et al. 2016 Canadian Cardiovascular Society Guidelines for the management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult. Can J Cardiol. 2016 doi: 10.1016/j.cjca.2016.07.510.